Evidentli appoints Jenny Morawska to the Board of Directors

Sydney, Australia. Evidentli, a global leader in medical research automation and translational

medicine announced today that Jenny Morawska has joined the Board of Directors.

Commenting on her appointment Guy Tsafnat, Founder and Chairman of Evidentli said, “We are

thrilled to attract a leader of Jenny’s calibre to our Board and we look forward to working with her in

continuing to chart Evidentli’s expansion in the coming years.”

Greg Miner, co-Founder and CEO stated, “Jenny possesses a rare combination of expertise in

corporate governance and a deep understanding of medical research. She will bring strong oversight

and counsel to our Board as we continue to transform the technical landscape surrounding medical

research and translational medicine.”

Jenny is an accomplished commercial businesswoman with deep experience as a Senior Executive

across multiple industries and diverse stakeholder groups. Her commercial acumen and successful

business career have been underpinned by her training as a research scientist and her further career

as a financier and banker. Jenny was one of the four most senior women in Australian Federal

Government. She is also a pragmatic commercial businesswoman who for the last 15 years has

worked on the global stage.

Her career includes: CEO of a Biotechnology Company; GM of an international Bank; Executive

Director of Price Waterhouse and Deputy CEO of the Federal Departments of Finance and Industry,

Science and Resources. She has a comprehensive understanding of global organisations, experience

in working across and within cultures, leading diverse teams and developing future leaders.

She is currently a Director of Research Australia where she Chairs the Strategy and Membership

Committee and is a Member of the Awards Committee; a Foundation Board Director of Queensland

Mind and Neuroscience – Thompson Institute; a member of the Governing Council of the University

of the Sunshine Coast and Member Risk, Governance and Performance Committee; and a Director of

the Lifeboat Foundation.

Jenny is also a visiting fellow at the Garvan Institute of Medical Research, and recently completed a

Google/NASA Fellowship in Exponential Technologies at Singularity University in Silicon Valley

reinforcing her deep knowledge of business and technology and current possibilities for business

models.

About Evidentli

Established in 2018, and based on 13 years of internationally funded research, Evidentli is a global

leader in the automation of medical research and translational medicine. Evidentli’s technology is

used by hospitals, research institutes, and government bodies in Australia and Europe.

Evidentli’s team is comprised of experienced informaticians who are thought leaders in digital

health, translational medicine, artificial intelligence in healthcare, and medical software

development. The team has cumulatively authored over 1000 papers in these fields and holds

leadership roles in international organisations such as the executive team of the International

Collaboration for the Automation of Systematic Reviews, The Cochrane Collaboration, and

Guidelines International Network.